BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26442421)

  • 1. [Perioperative Management of a Patient with Severe Parkinson's Disease with Intravenous Levodopa Administration].
    Terashima S; Yanagido Y; Watabe A; Yamane M; Morimoto Y
    Masui; 2015 Aug; 64(8):845-8. PubMed ID: 26442421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J; Kato S; Watada M; Morita S
    Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dose L-dopa infusion during general anesthesia for gastrectomy in a patient with parkinsonism].
    Horai T; Nishiyama T; Yamamoto H; Hanaoka K
    Masui; 2002 Jan; 51(1):42-5. PubMed ID: 11840662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia.
    Furuya R; Hirai A; Andoh T; Kudoh I; Okumura F
    Anesthesiology; 1998 Jul; 89(1):261-3. PubMed ID: 9667318
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations.
    Goetz CG; Pappert EJ; Blasucci LM; Stebbins GT; Ling ZD; Nora MV; Carvey PM
    Neurology; 1998 Feb; 50(2):515-7. PubMed ID: 9484386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.
    Fagerlund K; Anderson LC; Gurvich O
    Am J Nurs; 2013 Jan; 113(1):26-35; quiz 36. PubMed ID: 23247677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.
    Fujii T; Nakabayashi T; Hashimoto S; Kuwano H
    Surg Today; 2009; 39(9):807-10. PubMed ID: 19779780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease.
    Skalabrin EJ; Laws ER; Bennett JP
    Mov Disord; 1998 Sep; 13(5):775-81. PubMed ID: 9756145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
    Deleu D; Hanssens Y; Northway MG
    Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease.
    Catalán MJ; de Pablo-Fernández E; Villanueva C; Fernández-Diez S; Lapeña-Montero T; García-Ramos R; López-Valdés E
    Mov Disord; 2013 Dec; 28(14):2007-10. PubMed ID: 24123193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients.
    Sánchez-Castañeda C; Campdelacreu J; Miró J; Juncadella M; Jaumà S; Calopa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):250-1. PubMed ID: 19887096
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.
    Durif F; Devaux I; Pere JJ; Delumeau JC; Bourdeix I;
    Eur Neurol; 2001; 45(2):111-8. PubMed ID: 11244274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vitamin B(12) and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion.
    Santos-García D; Macías M; Llaneza M; Grande M; de la Fuente-Fernández R
    Mov Disord; 2011 Feb; 26(3):558-9. PubMed ID: 20960480
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Băjenaru O; Ene A; Popescu BO; Szász JA; Sabău M; Mureşan DF; Perju-Dumbrava L; Popescu CD; Constantinescu A; Buraga I; Simu M
    J Neural Transm (Vienna); 2016 Apr; 123(4):407-14. PubMed ID: 26699635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication.
    Salomone G; Marano M; di Biase L; Melgari JM; Di Lazzaro V
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552
    [No Abstract]   [Full Text] [Related]  

  • 19. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
    Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
    Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
    Ricciardi L; Bove F; Espay KJ; Lena F; Modugno N; Poon YY; Krikorian R; Espay AJ; Fasano A
    Mov Disord; 2016 Apr; 31(4):597-8. PubMed ID: 26946221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.